Uncategorized
Ozurdex works as adjunct treatment in diabetic macular edema
Patients with diabetic macular edema recalcitrant to anti-VEGF therapy and then treated with an intravitreal sustained-release 0.7 mg dexamethasone implant as part of a multimodal treatment experienced significant gains in visual acuity at a mean follow-up of 6 months, according to a study.DME is a multifaceted disease with ischemic and inflammatory mechanisms that can be treated with Ozurdex (dexamethasone intravitreal implant, Allergan), Zainab Khan, BHSc, MD, FRCSC, told Ocular Surgery News.